
Tango Health
Founded Year
2008Stage
Acquired | AcquiredTotal Raised
$10.17MAbout Tango Health
Tango Health is a provider of Health Savings Account (HSA) management software and services. The company offers an HSA management solution that serves the needs of an employer's entire population of HSA-eligible employees. Tango Health's user-friendly, web-based software provides visibility and control over HSA management. Tango sells directly to employers, and partners with custodial banks, insurance brokers, consultants, and insurance carriers to enhance offerings. On November 17th, 2021, Tango Health was acquired by Benefitfocus. The terms of the transaction were not disclosed.
Missing: Tango Health's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Tango Health's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Tango Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Tango Health is included in 5 Expert Collections, including HR Tech.
HR Tech
4,031 items
Insurtech
2,823 items
Companies and startups that use of technology to improve core and ancillary insurance operations. Companies in this collection are creating new product architectures, improving underwriting models, accelerating claims and creating a better customer experience
Fintech
7,985 items
US-based companies
Health Plans & Benefits Management
744 items
Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.
Digital Health
10,347 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Tango Health Patents
Tango Health has filed 1 patent.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/11/2010 | 3/5/2013 | Payment systems, International taxation, Debit cards, Banking, Stock market | Grant |
Application Date | 11/11/2010 |
---|---|
Grant Date | 3/5/2013 |
Title | |
Related Topics | Payment systems, International taxation, Debit cards, Banking, Stock market |
Status | Grant |
Latest Tango Health News
May 3, 2022
Delivered Revenue and Adjusted EBITDA in Excess of Guidance Ranges Executing on Strategic Plan to Return to Sustainable Growth CHARLESTON, S.C., May 03, 2022 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading cloud-based benefits administration technology company that simplifies benefits administration for employers, health plans and brokers, today announces its first quarter 2022 financial results: Financial Highlights for the First Quarter 2022: First quarter 2022 revenue of $61.2 million was above the high end of the guidance range of $59 to $61 million. Adjusted EBITDA of $11.2 million during the first quarter was above the high end of the guidance range of $7 to $9 million. GAAP net loss available to common stockholders was ($3.9) million, compared to ($3.7) million in the first quarter of 2021. GAAP loss per share was ($0.12) in the first quarter of 2022 and non-GAAP income per share was $0.01. Operational Highlights for the First Quarter: The recent acquisition of Tango Health delivered another ACA season with 100% ontime performance in client IRS filings. Migration of Benefitfocus clients to the Tango Health platform has now begun, which is expected to deliver even stronger client performance in all areas going forward. Selected for inclusion in Aon’s Connected Benefit Solution panel. Aon is one of the top brokers in the country. Kristin Adams was appointed as our new Chief People Officer, further enhancing and diversifying the leadership team. “We hit a number of strategic milestones in the quarter and we believe we are on our way to repositioning Benefitfocus for sustainable growth,” said Matt Levin, president and chief executive officer. “We have improved our go-to-market relationships and have a solid sales pipeline. We believe our efforts to date will enable us to grow market share and solidify our position as an industry leader.” “We were once again able to deliver financial results at or better than our guidance ranges for this quarter,” said Alpana Wegner, chief financial officer. “I am pleased with the progress we are making on executing our strategy to drive sustainable growth. We look forward to providing additional insight into our strategy and longer-term financial targets at our Investor Day on May 10.” First Quarter 2022 Financial Highlights Revenue Total revenue was $61.2 million, down approximately 6% compared to the first quarter of 2021. Software services was $49.7 million, down 7% compared to the first quarter of 2021. Software services is comprised of subscription and platform revenue. Subscription revenue was $43.1 million, down 5% compared to the first quarter of 2021. Platform revenue was $6.6 million, down 16% compared to the first quarter of 2021. Professional services revenue was $11.6 million, down 1% compared to the first quarter of 2021. Net Income GAAP net loss was ($2.3) million, compared to ($2.1) million in the first quarter of 2021. GAAP net loss per share was ($0.12), based on ($3.9) million net loss available to common stockholders and 33.5 million basic and diluted weighted average common shares outstanding. This compares to ($0.11) for the first quarter of 2021, based on ($3.7) million net loss available to common stockholders and 32.5 million basic and diluted weighted average common shares outstanding. Non-GAAP Net Income, Adjusted EBITDA and Free Cash Flow Non-GAAP net income available to common stockholders was $0.4 million for both the first quarter 2022 and 2021. Non-GAAP net income per share was $0.01 based on both 33.5 million basic and 35.2 million diluted weighted average common shares outstanding. This compares to $0.01 in the first quarter of 2021, based on both 32.5 million basic and 34.4 million diluted weighted average common shares outstanding. Adjusted EBITDA was $11.2 million, compared to $14.8 million in the first quarter of 2021. Cash used in operations was ($3.0) million and free cash flow was ($4.2) million, compared to cash from operations of $8.8 million and $8.3 million of free cash flow in the first quarter of 2021. See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below. Balance Sheet Cash, cash equivalents and restricted cash at March 31, 2022 totaled $59.0 million, compared to cash and cash equivalents and marketable securities of $68.1 million at the end of the of 2021, a decline driven by the timing of working capital changes. Our debt to Adjusted EBITDA ratio was 4.4x as of March 31, 2022. The full $50.0 million line of credit remains available to the company. Business Outlook Second Quarter 2022 Adjusted EBITDA is expected to be in the range of $4 million to $6 million. Non-GAAP net loss available to common stockholders is expected to be between ($6.0) million and ($4.0) million, or between ($0.17) and ($0.11) per share based on 34.0 million basic and diluted weighted average shares outstanding. Full Year 2022 Adjusted EBITDA is expected to be in the range of $44 million to $50 million. Free cash flow is expected to be in the range of $18 million to $24 million. Adjusted EBITDA and free cash flow guidance excludes the impact of restructuring and impairment charges. Management has not reconciled forward-looking non-GAAP net loss, adjusted EBITDA or free cash flow to their most directly comparable GAAP measure of GAAP net loss or GAAP operating cash flows. This is because we cannot predict with reasonable certainty the ultimate outcome of the various necessary GAAP components of such reconciliations, including, for example, those related to compensation, acquisition transactions and integration, or others that may arise during the year, without unreasonable effort. These components and other factors could materially impact the amount of future directly comparable GAAP measures, which may differ significantly from their non-GAAP counterparts. See below for additional important disclosures regarding our non-GAAP financial measures. Conference Call Details: In conjunction with this announcement, Benefitfocus will host a conference call to discuss the company’s financial results and business outlook on Tuesday, May 3, 2022, at 5:00 p.m. ET. To access this call, dial (877) 407-9208 (domestic) or +1 (201) 493-6784 (international). A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/ . After the conference call, a replay will be available until May 10, 2022 at 11:59 p.m. ET and can be accessed by dialing (844) 512-2921 (domestic) or +1 (412) 317-6671 (international) with passcode 13729373. About Benefitfocus Benefitfocus (NASDAQ: BNFT) is a cloud-based benefits administration technology company committed to helping our customers, and the people they serve, get the most out of their health care and benefit programs. Through exceptional service and innovative SaaS solutions, we aim to be the safest set of hands for our customers helping to simplify the complexity of benefits administration while delivering an experience that engages people and unlocks the potential for better health and improved outcomes. Our mission is simple: to improve lives with benefits. Non-GAAP Financial Measures The company uses certain non-GAAP financial measures in this release, including non-GAAP gross profit, operating income/loss, net loss/income, net loss/income per common share, adjusted EBITDA and free cash flow. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP gross profit, operating income/loss, net loss/income and net loss/income per common share exclude stock-based compensation expenses, amortization of acquisition-related intangible assets, transaction and acquisition-related costs expensed, expense related to the impairment of goodwill, intangible assets and long-lived assets, gain or loss on extinguishment of debt, and costs not core to our business. We define adjusted EBITDA as net loss before net interest, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense; transaction and acquisition-related costs expensed; restructuring costs; impairment of goodwill, intangible assets and long-lived assets; gain or loss on extinguishment of debt; other costs not core to our business; and loss on settlement of lawsuits. We define free cash flow as cash provided by or used in operating activities less capital expenditures, adjusted to eliminate cash paid for restructuring costs. Please note that other companies might define their non-GAAP financial measures differently than we do. Management presents these non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, their inclusion should provide consistency in the company’s financial reporting. Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release, including in the accompanying tables. Safe Harbor Statement Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our need to increase sales and achieve consistent GAAP profitability; fluctuations in our financial results; our ability to maintain our culture and recruit, integrate and retain qualified personnel, including on our board of directors; our ability to compete effectively and implement our growth strategy; our reliance on channel relationships; market developments and opportunities; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; the immature and volatile nature of the market for our products and services; privacy; security and other risks associated with our business; management of growth; volatility and uncertainty in the global economy and financial markets in light of the evolving COVID-19 pandemic and war in Ukraine; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our Investor Relations Department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law. Source: Benefitfocus, Inc.
Tango Health Frequently Asked Questions (FAQ)
When was Tango Health founded?
Tango Health was founded in 2008.
Where is Tango Health's headquarters?
Tango Health's headquarters is located at 9600 Great Hills Trail, Austin.
What is Tango Health's latest funding round?
Tango Health's latest funding round is Acquired.
How much did Tango Health raise?
Tango Health raised a total of $10.17M.
Who are the investors of Tango Health?
Investors of Tango Health include Benefitfocus, S3 Ventures, Mike Turner, John Hime and Kevin Cunningham.
Who are Tango Health's competitors?
Competitors of Tango Health include Bend Financial and 2 more.
Compare Tango Health to Competitors
Lively is a health savings account (HSA) platform for businesses and individuals. Its user-centric solutions enable sign-up, payroll syncing, paperless account management, and transparent pricing. It serves private individuals as well as businesses. The company was founded in 2016 and is based in San Francisco, California.

Pasito provides health and financial planning solutions to families and employees. It integrates payroll, financial, and claims data to optimize benefits coverage and utilization. It was founded in 2021 and is based in New York, New York.
Budgie Health translates complex healthcare data into simple financial experiences.

Fidelity Investments provides financial services and investment resources that help individuals and institutions meet financial objectives. It engages in investment management through its research company. The company was founded in 1946 and is based in Boston, Massachusetts.
Optum Bank provides health savings, spending accounts, stop loss services, electronic payment, and processing services. It is based in Salt Lake City, Utah.

HSA Bank specializes in consumer-directed healthcare (CDH), focusing on Health Savings Accounts (HSAs) and serving as both the bank and administrator. HSA Bank is a division of Webster Bank.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.